Apixaban in Patients with Atrial Fibrillation

Abstract

In patients with atrial fibrillation for whom vitamin K antagonist therapy was unsuitable, apixaban reduced the risk of stroke or systemic embolism without significantly increasing the risk of major bleeding or intracranial hemorrhage. (Funded by Bristol-Myers Squibb and Pfizer; ClinicalTrials.gov number, NCT00496769.).

Keywords

Atrial fibrillationApixabanCardiologyInternal medicineMedicineWarfarinRivaroxaban

Related Publications

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer , Nizar M. Tannir , Ray McDermott +29 more

Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...

2018 New England Journal of Medicine 4403 citations

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi , Steven O’Day , David F. McDermott +26 more

Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma. Adverse eve...

2010 New England Journal of Medicine 14794 citations

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian , F. Stephen Hodi , Julie R. Brahmer +27 more

Anti-PD-1 antibody produced objective responses in approximately one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse...

2012 New England Journal of Medicine 12335 citations

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

James Larkin , Vanna Chiarion‐Sileni , René González +28 more

BACKGROUND Nivolumab plus ipilimumab or nivolumab alone resulted in longer progression-free and overall survival than ipilimumab alone in a trial involving patients with advance...

2019 New England Journal of Medicine 3500 citations

Publication Info

Year: 2011
Type: article
Volume: 364
Issue: 9
Pages: 806-817
Citations: 2391
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Apixaban in Patients with Atrial Fibrillation

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2391

OpenAlex

Cite This

APA Style

                            
                                
                                    Stuart J. Connolly, 
                                
                                    John W. Eikelboom, 
                                
                                    Campbell Joyner
                                
                                et al.
                            
                            (2011). 
                            Apixaban in Patients with Atrial Fibrillation. 
                            New England Journal of Medicine
                            , 364
                            (9)
                            , 806-817.
                            https://doi.org/10.1056/nejmoa1007432
                        

Identifiers

DOI: 10.1056/nejmoa1007432